Session

Aspects of cirrhosis

ANTIBIOTIC PROPHYLAXIS IN CIRRHOSIS PATIENTS WITH UPPER GASTROINTESTINAL BLEEDING: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS
ANTIBIOTIC PROPHYLAXIS IN CIRRHOSIS PATIENTS WITH UPPER GASTROINTESTINAL BLEEDING: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS

USE OF LIVER TRANSIENT ELASTOGRAPHY ON THE PREDICTION OF THE PRESENCE OF OESOPHAGEAL VARICES IN PATIENTS WITH COMPENSATED ADVANCED CHRONIC LIVER DISEASE: IS THE AETIOLOGY RELEVANT?
USE OF LIVER TRANSIENT ELASTOGRAPHY ON THE PREDICTION OF THE PRESENCE OF OESOPHAGEAL VARICES IN PATIENTS WITH COMPENSATED ADVANCED CHRONIC LIVER DISEASE: IS THE AETIOLOGY RELEVANT?

SAFETY OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN PATIENTS WITH ADVANCED LIVER DISEASE
SAFETY OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN PATIENTS WITH ADVANCED LIVER DISEASE

EPIDEMIOLOGY OF MULTIDRUG-RESISTANT INFECTIONS IN PATIENTS WITH CIRRHOSIS HOSPITALIZED IN A GASTROENTEROLOGY DEPARTMENT IN PORTUGAL
EPIDEMIOLOGY OF MULTIDRUG-RESISTANT INFECTIONS IN PATIENTS WITH CIRRHOSIS HOSPITALIZED IN A GASTROENTEROLOGY DEPARTMENT IN PORTUGAL

EFFECTIVE ALBUMIN AS A NOVEL BIOMARKER IN THE ASSESSMENT OF CHILD-PUGH B AND C LIVER CIRRHOSIS
EFFECTIVE ALBUMIN AS A NOVEL BIOMARKER IN THE ASSESSMENT OF CHILD-PUGH B AND C LIVER CIRRHOSIS

CLINICAL SIGNIFICANCE OF SUBSTANTIALLY ELEVATED VON WILLEBRAND FACTOR ANTIGEN LEVELS IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
CLINICAL SIGNIFICANCE OF SUBSTANTIALLY ELEVATED VON WILLEBRAND FACTOR ANTIGEN LEVELS IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE

EFFECTIVE ALBUMIN AS A NOVEL BIOMARKER IN THE ASSESSMENT OF CHILD-PUGH B AND C LIVER CIRRHOSIS
EFFECTIVE ALBUMIN AS A NOVEL BIOMARKER IN THE ASSESSMENT OF CHILD-PUGH B AND C LIVER CIRRHOSIS

Aspects of cirrhosis

ANTIBIOTIC PROPHYLAXIS IN CIRRHOSIS PATIENTS WITH UPPER GASTROINTESTINAL BLEEDING: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS
ANTIBIOTIC PROPHYLAXIS IN CIRRHOSIS PATIENTS WITH UPPER GASTROINTESTINAL BLEEDING: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS

Aspects of cirrhosis

CLINICAL SIGNIFICANCE OF SUBSTANTIALLY ELEVATED VON WILLEBRAND FACTOR ANTIGEN LEVELS IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
CLINICAL SIGNIFICANCE OF SUBSTANTIALLY ELEVATED VON WILLEBRAND FACTOR ANTIGEN LEVELS IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE

Aspects of cirrhosis

SAFETY OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN PATIENTS WITH ADVANCED LIVER DISEASE
SAFETY OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN PATIENTS WITH ADVANCED LIVER DISEASE

Aspects of cirrhosis

USE OF LIVER TRANSIENT ELASTOGRAPHY ON THE PREDICTION OF THE PRESENCE OF OESOPHAGEAL VARICES IN PATIENTS WITH COMPENSATED ADVANCED CHRONIC LIVER DISEASE: IS THE AETIOLOGY RELEVANT?
USE OF LIVER TRANSIENT ELASTOGRAPHY ON THE PREDICTION OF THE PRESENCE OF OESOPHAGEAL VARICES IN PATIENTS WITH COMPENSATED ADVANCED CHRONIC LIVER DISEASE: IS THE AETIOLOGY RELEVANT?

Aspects of cirrhosis

EPIDEMIOLOGY OF MULTIDRUG-RESISTANT INFECTIONS IN PATIENTS WITH CIRRHOSIS HOSPITALIZED IN A GASTROENTEROLOGY DEPARTMENT IN PORTUGAL
EPIDEMIOLOGY OF MULTIDRUG-RESISTANT INFECTIONS IN PATIENTS WITH CIRRHOSIS HOSPITALIZED IN A GASTROENTEROLOGY DEPARTMENT IN PORTUGAL

Aspects of cirrhosis

CLINICAL SIGNIFICANCE OF SUBSTANTIALLY ELEVATED VON WILLEBRAND FACTOR ANTIGEN LEVELS IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
CLINICAL SIGNIFICANCE OF SUBSTANTIALLY ELEVATED VON WILLEBRAND FACTOR ANTIGEN LEVELS IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE

Aspects of cirrhosis  et al.

EFFECTIVE ALBUMIN AS A NOVEL BIOMARKER IN THE ASSESSMENT OF CHILD-PUGH B AND C LIVER CIRRHOSIS
EFFECTIVE ALBUMIN AS A NOVEL BIOMARKER IN THE ASSESSMENT OF CHILD-PUGH B AND C LIVER CIRRHOSIS

Aspects of cirrhosis  et al.

EPIDEMIOLOGY OF MULTIDRUG-RESISTANT INFECTIONS IN PATIENTS WITH CIRRHOSIS HOSPITALIZED IN A GASTROENTEROLOGY DEPARTMENT IN PORTUGAL
EPIDEMIOLOGY OF MULTIDRUG-RESISTANT INFECTIONS IN PATIENTS WITH CIRRHOSIS HOSPITALIZED IN A GASTROENTEROLOGY DEPARTMENT IN PORTUGAL

Aspects of cirrhosis  et al.

SAFETY OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN PATIENTS WITH ADVANCED LIVER DISEASE
SAFETY OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN PATIENTS WITH ADVANCED LIVER DISEASE

Aspects of cirrhosis  et al.

USE OF LIVER TRANSIENT ELASTOGRAPHY ON THE PREDICTION OF THE PRESENCE OF OESOPHAGEAL VARICES IN PATIENTS WITH COMPENSATED ADVANCED CHRONIC LIVER DISEASE: IS THE AETIOLOGY RELEVANT?
USE OF LIVER TRANSIENT ELASTOGRAPHY ON THE PREDICTION OF THE PRESENCE OF OESOPHAGEAL VARICES IN PATIENTS WITH COMPENSATED ADVANCED CHRONIC LIVER DISEASE: IS THE AETIOLOGY RELEVANT?

Aspects of cirrhosis  et al.

ANTIBIOTIC PROPHYLAXIS IN CIRRHOSIS PATIENTS WITH UPPER GASTROINTESTINAL BLEEDING: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS
ANTIBIOTIC PROPHYLAXIS IN CIRRHOSIS PATIENTS WITH UPPER GASTROINTESTINAL BLEEDING: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS

Aspects of cirrhosis  et al.

Item 1 - 18 / 18
1